| Product Information |
|
| Registration Number |
BR-1168
|
| Generic Name |
Human Papillomavirus 9-Valent Vaccine (Recombinant, Adsorbed)
|
| Brand Name |
Gardasil 9
|
| Dosage Strength |
Formulation: Each dose (0.5 mL) contains: Human Papillomavirus Type 6 L1 protein-30mcg Human Papillomavirus Type 11 L1 protein-40mcg Human Papillomavirus Type 16 Ll protein-60mcg Human Papillomavirus Type 18 Li protein-40mcg Human Papillomavirus Type 31 Ll protein-20 mcg Human Papillomavirus Type 33 L1 protein-20mcg Human Papillomavirus Type 45 Ll protein-20mcg Human Papillomavirus Type 52 L1 protein-20mcg Human Papillomavirus Type 58 LI protein-20mcg
Adsorbed on amorphous aluminum hydroxide sulphate adjuvant -500 mcg Al
|
| Dosage Form |
Suspension for Injection (IM)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
0.5 mL in 1.5 mL Type I pre-filled glass syringe with bromobutyl plunger stopper and tip cap + 2 sterile
needles (236 x 1" and 256 x 1") [Box of 1's]
|
| Pharmacologic Category |
-
|
| Manufacturer |
Merck Sharp & Dohme Corp.
|
| Country of Origin |
United States of America
|
| Trader |
N/A
|
| Importer |
Merck Sharp & Dohme (I.A.) LLC
|
| Distributor |
N/A
|
| Application Type |
Initial
|
| Issuance Date |
30 March 2022
|
| Expiry Date |
19 August 2026
|